| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections$ b& _! L# P8 F* ^) f9 ]
Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes
2 p1 h8 M1 |# u Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
, H* e% U$ c7 e4 U5 B/ C Press Release |
| 20. ( p3 R& G5 k& O+ N
: W$ v1 e( w# C1 ]8 f | | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers: O% u2 o ^1 D! M
Press Release |
| 19. | Kerydin
. K$ w' }2 K6 K+ F9 a, s
. t( L3 d( k% e | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
4 X/ _4 @! B- t+ k5 G. N+ J4 j (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) 3 v8 ^1 @9 w/ p. B7 I$ z3 J
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections
/ W* @% P3 A5 O! r+ s0 ?$ a5 |+ i Press Release |
| 16. | Jublia
- P+ j0 Z) n! h" P4 |8 b
8 E' e' [) w2 p | efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection). G) p8 Z F- d" q
No Press Release |
| 15. | Dalvance
: c d. H; l/ ^0 x+ H
1 B- _ u% _: |' X3 Q9 h9 @2 r | dalbavancin | 5/23/2014 | To treat adults with skin infections
% x, Z% B& w5 b Press Release |
| 14. | Entyvio
# ^, F, a7 S" o7 Q3 m
' h, ~ i9 b3 e1 b8 L: p) U | vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease
+ X7 j1 b" E: C6 P: i4 C Press Release |
| 13. | Zontivity- `0 R+ G: F1 y6 Q- ~/ S
- z1 d; N) `5 E0 R% v* b | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients1 \6 Q E+ m+ ^6 Q8 E. ~) L
Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)7 M7 A `7 F) j7 V$ [# y9 a
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)
' _; `, L3 M3 s! p3 n; L Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma' o$ ~5 r! q, G4 Z0 D
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
5 M# j. ?3 `# |* v" I9 F Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)& M1 u7 \ `5 u
Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis, |, z# G, D2 G
Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency
. J/ X3 ?( v4 t6 W, L7 p6 s Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)7 P8 P+ g6 j! Z
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)$ m9 Q0 ^# x* c$ Z1 f
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes' i4 P6 I8 R r2 A4 h3 H
Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对